Market Indices
Sector Heatmap
PTGX — Protagonist Therapeutics, Inc
NasdaqProtagonist Therapeutics, Inc
- O
- 137.34
- H
- 144.10
- L
- 137.25
- V
- 927.26K
PTGX — Latest News & Headlines
18 StoriesProtagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts - MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts MarketBeat
After exercising options, Protagonist Therapeutics (PTGX) CFO sells 58,629 shares under a trading plan. - Stock Titan
After exercising options, Protagonist Therapeutics (PTGX) CFO sells 58,629 shares under a trading plan. Stock Titan
Protagonist Therapeutics(PTGX.US) Officer Sells US$8.31 Million in Common Stock - Moomoo
Protagonist Therapeutics(PTGX.US) Officer Sells US$8.31 Million in Common Stock Moomoo
Protagonist Therapeutics (PTGX) Could Be 25% Undervalued On Its Royalty Backed Story - Simply Wall Street
Protagonist Therapeutics (PTGX) Could Be 25% Undervalued On Its Royalty Backed Story Simply Wall Street
PTGX Jan 2027 145.000 call (PTGX270115C00145000) Stock Price, News, Quote & History - Yahoo! Finance Canada
PTGX Jan 2027 145.000 call (PTGX270115C00145000) Stock Price, News, Quote & History Yahoo! Finance Canada
Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today - Benzinga
Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today Benzinga
(PTGX) Volatility Zones as Tactical Triggers - Stock Traders Daily
(PTGX) Volatility Zones as Tactical Triggers Stock Traders Daily
Officer Asif Ali plans to sell 58,629 Protagonist Therapeutics (PTGX) shares. - Stock Titan
Officer Asif Ali plans to sell 58,629 Protagonist Therapeutics (PTGX) shares. Stock Titan
Protagonist Therapeutics (PTGX) Insider Trading Activity 2026 - MarketBeat
Protagonist Therapeutics (PTGX) Insider Trading Activity 2026 MarketBeat
PTGX Apr 2027 155.000 call (PTGX270416C00155000) Stock Price, News, Quote & History - Yahoo! Finance Canada
PTGX Apr 2027 155.000 call (PTGX270416C00155000) Stock Price, News, Quote & History Yahoo! Finance Canada
Protagonist Therapeutics stock fell 1.38 percent on October 6 - AD HOC NEWS
Protagonist Therapeutics stock fell 1.38 percent on October 6 AD HOC NEWS
Possible Bearish Signals With Protagonist Therapeutics Insiders Disposing Stock - Moomoo
Possible Bearish Signals With Protagonist Therapeutics Insiders Disposing Stock Moomoo
Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 58,629 Shares of Company Stock - MarketBeat
Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 58,629 Shares of Company Stock MarketBeat
PTGX Jan 2027 145.000 call (PTGX270115C00145000) Interactive Stock Chart - Yahoo! Finance Canada
PTGX Jan 2027 145.000 call (PTGX270115C00145000) Interactive Stock Chart Yahoo! Finance Canada
Protagonist Therapeutics stock gains 1.47 percent on Nasdaq 2026-10-05 - AD HOC NEWS
Protagonist Therapeutics stock gains 1.47 percent on Nasdaq 2026-10-05 AD HOC NEWS
PTGX Jan 2027 195.000 call (PTGX270115C00195000) Interactive Stock Chart - Yahoo! Finance Canada
PTGX Jan 2027 195.000 call (PTGX270115C00195000) Interactive Stock Chart Yahoo! Finance Canada
Protagonist Therapeutics stock gets USD 300.0 million buyback approval - AD HOC NEWS
Protagonist Therapeutics stock gets USD 300.0 million buyback approval AD HOC NEWS
PTGX270115P00160000 Interactive Stock Chart | PTGX Jan 2027 160.000 put Stock - Yahoo Finance
PTGX270115P00160000 Interactive Stock Chart | PTGX Jan 2027 160.000 put Stock Yahoo Finance